Analyst firms · Piper Sandler · STE
Piper Sandler STE price target and rating history
STERIS plc (Ireland) (STE) · Health Care
Piper Sandler rates STERIS plc (Ireland) (STE) Overweight with a $260 price target, as of its latest action on Oct 24, 2024. It has published 3 rating actions on STE since July 2022, including 1 upgrade and 1 downgrade.
- Current rating
- Overweight
- Price target
- $260
- Median target, all firms
- Too few
- Actions on STE
- 3
Piper Sandler price target on STE
Every Piper Sandler rating on STE
- Oct 24, 2024
- Apr 14, 2023
- Jul 14, 2022
How other firms rate STE
Each firm's latest rating and stated target in the last 12 months.
Questions about Piper Sandler and STE
- What is Piper Sandler's price target for STE?
- Piper Sandler's latest stated price target for STERIS plc (Ireland) (STE) is $260, from its action on Oct 24, 2024.
- What is Piper Sandler's rating on STE?
- Piper Sandler rates STE Overweight, a bullish rating, as of Oct 24, 2024.
- When did Piper Sandler last change its view on STE?
- On Oct 24, 2024, Piper Sandler upgrades to Overweight from Neutral, price target $230 to $260.
More STE rating histories
All Piper Sandler ratingsSTE news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.